X4 Pharmaceuticals: Q4 Earnings Snapshot

BOSTON (AP) — BOSTON (AP) — X4 Pharmaceuticals, Inc. (XFOR) on Thursday reported a loss of $19.1 million in its fourth quarter.

On a per-share basis, the Boston-based company said it had a loss of 10 cents.

The results exceeded Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of 15 cents per share.

For the year, the company reported a loss of $101.2 million, or 57 cents per share.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on XFOR at https://www.zacks.com/ap/XFOR